# Rocket Companies, Inc.: overview

RKT · NYSE · CIK 1805284 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/rkt.md) · [Financials](/companies/rkt/financials.md) · [Filings](/companies/rkt/filings.md) · [Insiders](/companies/rkt/insiders.md)

Latest reported revenue: [$2.78bn](/filings/0001628280-26-054577.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 7, 2026 (XBRL us-gaap:RevenuesNetOfInterestExpense, accession 0001628280-26-054577).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [647](/filings/0001805284-25-000136.md) | [1,770 d](/filings/0001628280-26-013283.md) | [1,101](/filings/0001628280-26-033694.md) | [1,451](/filings/0001628280-26-054577.md) | [1,605](/filings/0001805284-25-000136.md) | [2,692 d](/filings/0001628280-26-013283.md) | [2,941](/filings/0001628280-26-033694.md) | [2,784](/filings/0001628280-26-054577.md) |
| Gross margin | % | [(8.4%)](/filings/0001805284-24-000176.md) | [58.9% d](/filings/0001805284-25-000010.md) | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [(3.4%)](/filings/0001805284-25-000136.md) | [1.9% d](/filings/0001628280-26-013283.md) | [(0.9%)](/filings/0001628280-26-033694.md) | [(0.1%)](/filings/0001628280-26-054577.md) | [(7.7%)](/filings/0001805284-25-000136.md) | [2.5% d](/filings/0001628280-26-013283.md) | [10.1%](/filings/0001628280-26-033694.md) | [8.3%](/filings/0001628280-26-054577.md) |
| Diluted EPS | $ per share | [(0.19)](/filings/0001805284-25-000136.md) | not reported | [(0.08)](/filings/0001628280-26-033694.md) | [(0.01)](/filings/0001628280-26-054577.md) | [(0.06)](/filings/0001805284-25-000136.md) | not reported | [0.10](/filings/0001628280-26-033694.md) | [0.08](/filings/0001628280-26-054577.md) |
| Free cash flow | $m | [(1,356) d](/filings/0001805284-25-000136.md) | [1,823 d](/filings/0001628280-26-013283.md) | [(810)](/filings/0001628280-26-033694.md) | [(1,868) d](/filings/0001628280-26-054577.md) | [(70.4) d](/filings/0001805284-25-000136.md) | [(1,270) d](/filings/0001628280-26-013283.md) | [1,814](/filings/0001628280-26-033694.md) | [(1,246) d](/filings/0001628280-26-054577.md) |

- Revenue. XBRL Revenue: us-gaap:RevenuesNetOfInterestExpense. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenuesNetOfInterestExpense. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:RevenuesNetOfInterestExpense. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenuesNetOfInterestExpense. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $bn | [12.9](/filings/0001805284-24-000009.md) | [5.8](/filings/0001805284-25-000010.md) | [3.8](/filings/0001628280-26-013283.md) | [5.1](/filings/0001628280-26-013283.md) | [6.7](/filings/0001628280-26-013283.md) |
| Gross margin | % | [63.9%](/filings/0001805284-24-000009.md) | [44.5%](/filings/0001805284-25-000010.md) | [34.4%](/filings/0001805284-25-000010.md) | [45.3%](/filings/0001805284-25-000010.md) | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [2.4%](/filings/0001805284-24-000009.md) | [0.8%](/filings/0001805284-25-000010.md) | [(0.4%)](/filings/0001628280-26-013283.md) | [0.6%](/filings/0001628280-26-013283.md) | [(1.0%)](/filings/0001628280-26-013283.md) |
| Diluted EPS | $ per share | [2.32](/filings/0001805284-24-000009.md) | [0.28](/filings/0001805284-25-000010.md) | [(0.15)](/filings/0001628280-26-013283.md) | [0.21](/filings/0001628280-26-013283.md) | [(0.05)](/filings/0001628280-26-013283.md) |
| Free cash flow | $bn | [7.6](/filings/0001805284-24-000009.md) | [10.7](/filings/0001805284-25-000010.md) | [0.1](/filings/0001628280-26-013283.md) | [(2.7)](/filings/0001628280-26-013283.md) | [(4.0)](/filings/0001628280-26-013283.md) |

- Revenue. XBRL Revenue: us-gaap:RevenuesNetOfInterestExpense.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenuesNetOfInterestExpense.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:RevenuesNetOfInterestExpense.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenuesNetOfInterestExpense.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/rkt/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [Capital World Investors](/funds/1422849.md) | 2026-06-30 | $1.09bn | 69,332,560 |  | New +69,332,560 |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $1.09bn | 69,066,062 |  | Added +2,473,904 |
| [FMR LLC](/funds/315066.md) | 2026-06-30 | $820.0m | 52,060,648 |  | Added +20,382,974 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $672.4m | 42,689,718 |  | Added +1,014,007 |
| [ValueAct Holdings, L.P.](/funds/1418814.md) | 2026-06-30 | $656.3m | 41,668,774 |  | Added +13,454,050 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $637.9m | 40,503,401 |  | Added +951,151 |
| [Capital International Investors](/funds/1562230.md) | 2026-06-30 | $526.2m | 33,407,832 |  | Added +29,754,919 |
| [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $449.5m | 28,542,001 |  | Added +5,948,345 |
| [GOLDMAN SACHS GROUP INC](/funds/886982.md) | 2026-06-30 | $365.8m | 23,227,764 |  | Added +14,190,099 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $350.7m | 22,268,377 |  | Added +722,909 |

## Recent filings

[All 683 filings](/companies/rkt/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-30 | 07:31 ET | [10-Q](/filings/0001628280-26-068434.md) | Quarterly report, period 2026-09-30 | 0001628280-26-068434 |
| 2026-10-29 | 17:19 ET | [8-K](/filings/0001805284-26-000121.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001805284-26-000121 |
| 2026-08-17 | 16:07 ET | [8-K](/filings/0001628280-26-057366.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-057366 |
| 2026-08-07 | 07:31 ET | [10-Q](/filings/0001628280-26-054577.md) | Quarterly report, period 2026-06-30 | 0001628280-26-054577 |
| 2026-08-06 | 17:24 ET | [8-K](/filings/0001805284-26-000082.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001805284-26-000082 |
| 2026-07-16 | 16:05 ET | [8-K](/filings/0000950142-26-002106.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation | 0000950142-26-002106 |
| 2026-06-16 | 16:05 ET | [8-K](/filings/0000950142-26-001804.md) | 1.01 Entry into a material agreement | 0000950142-26-001804 |
| 2026-06-10 | 17:21 ET | [8-K](/filings/0001805284-26-000070.md) | 5.07 Shareholder vote results | 0001805284-26-000070 |
| 2026-06-10 | 19:33 ET | [8-K](/filings/0000950142-26-001715.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950142-26-001715 |
| 2026-06-09 | 08:35 ET | [8-K](/filings/0001104659-26-071607.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-071607 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001628280-26-013283.md), filed Mar 2, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, locked when the 8-K was accepted. It is scored when the 10-Q or 10-K is ingested. [See the target](/leagues/2026q3/targets/07c999b9-c8ce-4355-93ad-e808480f69df)

## About the filer

- CIK: 1805284
- Tickers: RKT
- Exchange: NYSE
- SIC code: 6162 Mortgage Bankers & Loan Correspondents
- State of incorporation: MI
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 30, 2026, 12:37 ET. No prices; not investment advice.